Clinical Trials on Low-grade Serous Ovarian Carcinoma
Total 6468 results
-
Peking University People's HospitalBeijing Weixiao Biotechnology Development LimitedRecruitingRecurrent Ovarian Carcinoma | Platinum-resistant Ovarian CancerChina
-
CanariaBio Inc.Gynecologic Oncology Group; Iqvia Pty LtdActive, not recruitingOvarian Neoplasms | Fallopian Tube Neoplasms | Peritoneal Neoplasms | Carcinoma, Ovarian Epithelial | Ovarian Cancer | Peritoneal Carcinoma | Peritoneal Cancer | Fallopian Tube Adenocarcinoma | Fallopian Tube Serous Adenocarcinoma | Ovarian Serous AdenocarcinomaKorea, Republic of, United States, Taiwan, Czechia, Argentina, Spain, Belgium, Brazil, Chile, Canada, Italy, Hungary, India, Mexico
-
National Cancer Institute (NCI)TerminatedOvarian CarcinomaUnited States, Israel
-
CHU de Quebec-Universite LavalThe Cancer Research SocietyCompleted
-
All India Institute of Medical Sciences, New DelhiUnknown
-
University of ChicagoVisualase, Inc.Completed
-
National Cancer Institute (NCI)Active, not recruitingEndometrial Atypical Hyperplasia/Endometrioid Intraepithelial Neoplasia | FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma | FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma | Atypical HyperplasiaUnited States
-
University of Wisconsin, MadisonAventis PharmaceuticalsCompletedOvarian Carcinoma | Primary Peritoneal CarcinomaUnited States
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)WithdrawnRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Malignant Ovarian Clear Cell Tumor | Stage IIIA Fallopian Tube Cancer | Stage IIIA Ovarian Cancer | Stage IIIA Primary Peritoneal Cancer | Stage IIIB Fallopian Tube Cancer | Stage IIIB Ovarian... and other conditions
-
Seoul National University HospitalUnknownFallopian Tube Carcinoma | Primary Peritoneal Carcinoma | Epithelial Ovarian CarcinomaKorea, Republic of
-
University Hospital, MontpellierCompletedLow-grade GliomaFrance
-
Institut de Cancérologie de LorraineCompleted
-
Rennes University HospitalCompletedOvarian CarcinomaFrance
-
University Hospital, Basel, SwitzerlandWithdrawnEndometriosis | Endometrioid Carcinoma | Clear Cell Carcinoma
-
Sutro Biopharma, Inc.RecruitingOvarian Cancer | Fallopian Tube Cancer | Ovarian Carcinoma | Ovary Cancer | Primary Peritoneal CarcinomaUnited States
-
Lei LiRecruitingEpithelial Ovarian Cancer | Microsatellite Instability | PD-L1 | Nucleotide Variant | Copy Number Variation | Insertion-deletion Variation | Genomic Structural Variation | Total Mutation Burden | PD-1China
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Sprint for LifeCompletedOvarian Endometrioid Adenocarcinoma | Ovarian Seromucinous Carcinoma | Ovarian Undifferentiated Carcinoma | Ovarian Clear Cell Adenocarcinoma | Ovarian Mucinous Adenocarcinoma | Fallopian Tube Clear Cell Adenocarcinoma | Fallopian Tube Endometrioid Adenocarcinoma | Fallopian Tube Mucinous Adenocarcinoma and other conditionsUnited States
-
Albert Einstein College of MedicineNational Cancer Institute (NCI)CompletedPeritoneal Neoplasms | Recurrent Ovarian Carcinoma | Recurrent Uterine Corpus Carcinoma | Cervical Carcinoma | Ovarian Carcinoma | Recurrent Cervical Carcinoma | Uterine Corpus Cancer | Vulvar Carcinoma | Primary Peritoneal Carcinoma | Recurrent Vulvar CarcinomaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedRecurrent Fallopian Tube Carcinoma | Recurrent Primary Peritoneal Carcinoma | Recurrent Ovarian Epithelial CancerUnited States
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)Not yet recruitingFallopian Tube Carcinoma | Ovarian Carcinoma | Hereditary Breast and Ovarian Cancer Syndrome | Primary Peritoneal CarcinomaUnited States
-
GlaxoSmithKlineCompletedNeoplasms, OvarianUnited States
-
Life Research Technologies GmbHUnknownOvarian Epithelial CancerAustria, Hungary
-
Mercy Medical CenterActive, not recruitingFallopian Tube Cancer | Epithelial Ovarian Cancer | Fallopian Tube Carcinoma | Ovarian Carcinoma | Primary Peritoneal Carcinoma | Stage IV Ovarian Cancer | Stage III Ovarian CancerUnited States
-
The First People's Hospital of ChangzhouActive, not recruiting
-
University of Illinois at ChicagoCompletedPrimary Ovarian Insufficiency | Premature Ovarian Failure | Low Ovarian ReserveUnited States
-
Sutro Biopharma, Inc.RecruitingOvarian Cancer | Fallopian Tube Cancer | Endometrial Cancer | Ovarian Carcinoma | Endometrioid Adenocarcinoma | Ovary Cancer | Primary Peritoneal CarcinomaUnited States, Spain
-
University of WashingtonNational Cancer Institute (NCI)CompletedCaregiver | Stage IIIA Ovarian Cancer | Stage IIIB Ovarian Cancer | Stage IIIC Ovarian Cancer | Stage IV Ovarian CancerUnited States
-
AstraZenecaRTI Health Solutions; A+A Healthcare Marketing Research; Freelance CRA (FCRA)CompletedPlatinum-sensitive Recurrent Serous Ovarian CancerFrance, Italy, Korea, Republic of, Spain, United Kingdom, Germany, Belgium, Israel, Portugal, Netherlands, Switzerland, Canada, Australia
-
National Cancer Institute (NCI)CompletedRecurrent Ovarian Carcinoma | Fallopian Tube Carcinoma | Primary Peritoneal Carcinoma | Stage IV Ovarian Cancer | Stage III Ovarian Cancer | Recurrent Borderline Ovarian Surface Epithelial-Stromal Tumor | Stage III Borderline Ovarian Surface Epithelial-Stromal Tumor | Stage IV Borderline Ovarian...Canada
-
University Hospital HeidelbergRecruiting
-
West China HospitalRecruiting
-
Day One Biopharmaceuticals, Inc.Available
-
The Hospital for Sick ChildrenHoffmann-La RocheActive, not recruitingLow Grade GliomaUnited States, Canada, Australia, New Zealand
-
Assistance Publique - Hôpitaux de ParisCompletedBarrett Oesophagus | Low Grade DysplasiaFrance
-
Maastricht Radiation OncologyHeidelberg University; University of Giessen; University Medical Center Nijmegen and other collaboratorsCompleted
-
Cancer Trials IrelandActive, not recruitingFallopian Tube Cancer | Primary Peritoneal Carcinoma | Serous Ovarian Tumor | Endometrioid Carcinoma OvaryIreland
-
ARCAGY/ GINECO GROUPMerck Sharp & Dohme LLCRecruitingAddition of Pembrolizumab to the Standard of Care Chemotherapy in Patient With SCCOHT (PembroSCCOHT)Small Cell Ovarian CarcinomaFrance
-
National Cancer Institute (NCI)RecruitingRecurrent Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | Recurrent Platinum-Resistant Ovarian Carcinoma | Refractory Ovarian CarcinomaUnited States
-
NYU Langone HealthCompletedMicrovascular Ultrasonographic Imaging for the Detection of Early Stage Epithelial Ovarian CarcinomaOvarian NeoplasmsUnited States
-
QuantumLeap Healthcare CollaborativeByondis B.V.WithdrawnOvarian Cancer | Metastatic Cancer | Metastatic Breast Cancer | Bladder Cancer | Triple Negative Breast Cancer | HER2-positive Breast Cancer | Gastroesophageal Adenocarcinoma | Ovarian Carcinoma | HER2-positive Gastric Cancer | Metastatic Gastrointestinal Carcinoid Tumor | HER2-positive Metastatic Breast... and other conditionsUnited States
-
Lei LiRecruitingChemotherapy | Ovarian Carcinoma | Survival Outcomes | Adverse Events | Niraparib | Anlotinib | CA125 | Targeted Therapy | Recurrent Ovarian CancerChina
-
Dwight OwenBristol-Myers SquibbActive, not recruitingNeuroendocrine Tumors | Small-cell Lung Cancer | Neuroendocrine Carcinoma | Large Cell Neuroendocrine Carcinoma | Lung Cancer Stage IV | Recurrent Small Cell Lung Carcinoma | Refractory Small Cell Lung Carcinoma | Metastatic Neuroendocrine Carcinoma | Grade I Neuroendocrine Carcinoma | Grade II Neuroendocrine... and other conditionsUnited States
-
Dana-Farber Cancer InstituteImmunityBio, Inc.Not yet recruitingOvarian Cancer | Platinum-resistant Ovarian Cancer | Ovarian Carcinoma | Recurrent Ovary Cancer | Ovarian Carcinoma, RecurrentUnited States
-
Day One Biopharmaceuticals, Inc.SIOPe Brain Tumor Group LOGGIC ConsortiumRecruitingLow-grade GliomaUnited States, Korea, Republic of, France, Germany, Spain, United Kingdom, Belgium, Denmark, Canada, Italy, Finland, Australia, Ireland, Switzerland, Netherlands, Czechia, Greece, New Zealand, Slovenia, Sweden, Hungary, Singapore, A... and more
-
Karen D. Wright, MDNational Cancer Institute (NCI); Pacific Pediatric Neuro-Oncology Consortium; Day One Biopharmaceuticals, Inc... and other collaboratorsActive, not recruiting
-
Massachusetts General HospitalNational Cancer Institute (NCI)CompletedLow Grade GliomasUnited States
-
SCRI Development Innovations, LLCMillennium Pharmaceuticals, Inc.; CephalonCompleted
-
University Hospital, ToulouseCompleted
-
Genzyme, a Sanofi CompanyCompletedLymphoma, Low-GradeJapan
-
Alberta Health servicesCompletedLow Grade LymphomaCanada